Detailed text transcripts for TV channel - MSNBC - 20180613:15:47:00
Who've tried an fda-approved targeted therapy, who wouldn't want a chance for another...? who'd say no to a...? who wouldn't want a chance to live longer. opdivo (nivolumab). over 40,000 patients have been prescribed opdivo immunotherapy. opdise your immune system to attack normal organs and tissues in your body and affect how they work. this may happen during or after treatment has ended, and may become serious and lead to death. see your doctor right away if you experience new or worsening cough; che pain; shortness of breath; diarrhea; severe stomach pain or tenderness; severe nausea or vom...
Source: news source